awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q51737719-D1C16698-EA28-4883-A6C4-E41274913D92
Q51737719-D1C16698-EA28-4883-A6C4-E41274913D92
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51737719-D1C16698-EA28-4883-A6C4-E41274913D92
Interaction of the Sodium/Glucose Cotransporter (SGLT) 2 inhibitor Canagliflozin with SGLT1 and SGLT2.
P2860
Q51737719-D1C16698-EA28-4883-A6C4-E41274913D92
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51737719-D1C16698-EA28-4883-A6C4-E41274913D92
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1093881cf9d9d2c8f50545d09d4c21eaf053bbb1
P2860
Canagliflozin improves glycaemic control over 28 days in subjects with type 2 diabetes not optimally controlled on insulin.